Conference · Boston, Massachusetts
Antibody-Drug Conjugates 2013
Health · Medicine · Pharmaceuticals
Dates2–3 May 2013This edition has ended
RunningSince 2011Annual · 6 editions on record
Last checked12 Nov 2026Organiser website checked
This is the 2013 edition. It has ended. See Antibody-Drug Conjugates's current page for the next dates.
Key numbers
- Editions on record
- 6first in 2011
About Antibody-Drug Conjugates
Antibody-drug conjugates (ADCs) in late-stage clinical development have shown encouraging therapeutic effects against both solid tumors and hematological malignancies. Significant progress has been made through optimization of parameters including specificity, potency, linker technology, conjugate site design, and the stoichiometry and placement of drugs. These sessions will showcase the design and discovery of next generation ADC’s, leveraging current knowledge from successful clinical candidates.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2027 | 10–14 May 2027 Dates announced | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2015 | 2–3 May 2015 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2014 | 8–9 May 2014 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2013 | 2–3 May 2013 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2012 | 3–4 May 2012 | The Boston Park Plaza Boston, Massachusetts | — | — |
| 2011 | 12–13 May 2011 | Sheraton Boston Hotel & Towers Boston, Massachusetts | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.